ArticleCurrent therapeutic research, clinical and experimental

A Multicenter, Randomized, Open-Label Trial: Efficacy of Once-Daily Versus Twice-Daily Double-Dose Rabeprazole on Refractory Gastroesophageal Reflux Disease-Related Symptoms and Quality of Life.

Akira Mizuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.